Skip to main content
Alteogen Inc. logo

Alteogen Inc. — Investor Relations & Filings

Ticker · 196170 ISIN · KR7196170005 KO Professional, scientific and technical activities
Open in API
Filings indexed 293 across all filing types
Latest filing 2025-02-04 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 196170

About Alteogen Inc.

http://www.alteogen.com/

Alteogen Inc. is a biopharmaceutical company focused on the development and commercialization of next-generation biologics. The company's core activities are centered on its proprietary platform technologies. These include Hybrozyme™, a novel recombinant human hyaluronidase (ALT-B4) technology that enables the conversion of intravenous (IV) therapies to subcutaneous (SC) formulations, enhancing patient convenience. Additionally, Alteogen develops long-acting biobetters utilizing its NexP™ fusion technology, proprietary antibody-drug conjugates (ADCs), and antibody biosimilars. The company's pipeline is aimed at creating therapies with enhanced efficacy and delivery methods for serious diseases.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Alteogen, specifically detailing a 'Decision on Paid-in Capital Increase' (유상증자 결정). It outlines the issuance of new shares, including details on third-party allocation, share types, conversion rights, and redemption terms. This is a formal regulatory filing regarding capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2025-02-04 Korean
풍문또는보도에대한해명(미확정)
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure from a Korean company (Alteogen) responding to media rumors regarding a potential capital raise (RCPS issuance). It is a standard 'Clarification of Rumors or Reports' filing required by the Korea Exchange (KRX). Since it does not fit into specific categories like M&A, dividends, or director dealings, and serves as a general regulatory update regarding market rumors, it is classified as a Regulatory Filing (RNS).
2025-01-20 Korean
불성실공시법인미지정 (공시번복 2건)
Regulatory Filings Classification · 100% confidence The document is a short regulatory notice from the Korea Exchange regarding the status of a company (Alteogen) as a 'non-designated' entity for unfair disclosure practices. It details the decision date, the reason for non-designation, and references specific regulatory rules. Since it is a regulatory announcement regarding compliance status and does not fit into specific categories like financial reports or shareholder meetings, it falls under the general regulatory filing category.
2025-01-15 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '임시주주총회결과' (Extraordinary General Meeting Results) and provides the outcome of specific agenda items (approval of articles of incorporation changes) voted on during the meeting held on 2024-12-26. This falls under the category of Declaration of Voting Results.
2024-12-26 Korean
불성실공시법인지정예고 (공시번복 2건)
Regulatory Filings Classification · 100% confidence The document is a formal notice from the Korea Exchange regarding the 'designation of an unfaithful disclosure corporation' (불성실공시법인지정예고) for Alteogen. This is a regulatory notification concerning disclosure violations (cancellation of merger and acquisition decisions). Since it pertains to regulatory compliance and legal/disclosure status rather than financial results, dividends, or management changes, it falls under the general regulatory filing category.
2024-12-24 Korean
풍문또는보도에대한해명(미확정)
Regulatory Filings Classification · 100% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) titled 'Clarification on Rumors or Reports'. It addresses specific media reports regarding a potential capital financing activity (RCPS issuance) and clarifies that no such decision has been finalized. Since it is a regulatory disclosure regarding market rumors and does not fit into specific categories like M&A or capital updates (as it is a clarification of a rumor rather than an announcement of a transaction), it falls under the general regulatory filing category.
2024-12-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.